TRAC-CAR T Cells (19(T2)28z1xx)

· Memorial Sloan Kettering Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TRAC-CAR T Cells (19(T2)28z1xx), covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Study of 19(T2)28z1xx TRAC-Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Lymphoma [Phase 1]